Most Common Pathogen in Intraabdominal Abscess
Escherichia coli is the most common pathogen in intraabdominal abscesses, isolated in 71% of cases, followed closely by anaerobic organisms, particularly Bacteroides fragilis (35%) and other Bacteroides species (71%). 1
Polymicrobial Nature of Infection
Intraabdominal abscesses are characteristically polymicrobial, with an average of five organisms present: three anaerobes and two aerobes. 2 The infection reflects the endogenous flora of the gastrointestinal tract, with the specific microbiology depending on the anatomical source of contamination. 1
Dominant Pathogens by Category
Gram-Negative Aerobic/Facultative Organisms
- E. coli dominates at 71% of microbiologically confirmed complicated intra-abdominal infections 1
- Klebsiella species appear in 14% of cases 1
- Pseudomonas aeruginosa in 14% 1
- Proteus mirabilis in 5% 1
- Enterobacter species in 5% 1
Anaerobic Organisms
- Bacteroides fragilis is isolated in 35% of complicated intra-abdominal infections 1
- Other Bacteroides species collectively appear in 71% of cases 1
- Clostridium species in 29% 1
- Peptostreptococcus species in 17% 1
- Prevotella species in 12% 1
Gram-Positive Organisms (Secondary Contributors)
- Streptococcus species in 38% of cases 1
- Enterococcus faecalis in 12% 1
- Staphylococcus aureus in only 4% 1
Anatomical Source Determines Microbiology
The specific pathogens vary based on the source of perforation or infection:
- Distal small bowel, appendiceal, and colon-derived infections harbor both facultative gram-negative organisms (especially E. coli) and obligate anaerobes (especially B. fragilis) 1, 3
- Proximal gastrointestinal perforations (stomach, duodenum, biliary system) contain predominantly gram-positive and gram-negative aerobic/facultative organisms with fewer anaerobes 1
- Colon-derived infections consistently involve facultative or obligate anaerobic organisms, with B. fragilis being the dominant anaerobic pathogen 1, 3
Clinical Implications for Empiric Coverage
Empiric antimicrobial therapy must cover both E. coli and B. fragilis as these represent the most clinically significant pathogens in terms of morbidity and mortality. 1 The Infectious Diseases Society of America and Surgical Infection Society guidelines emphasize that antibiotics must be active against enteric gram-negative aerobic/facultative bacilli AND obligate anaerobic bacilli for distal small bowel, appendiceal, and colon-derived infections. 1
Key Coverage Considerations
- Enterococcal coverage is NOT routinely necessary in community-acquired intra-abdominal infections despite its presence in 12-23% of cases 1
- Antifungal coverage for Candida is NOT recommended for community-acquired infections 1
- Metronidazole provides uniform coverage against B. fragilis, as does carbapenems and certain β-lactam/β-lactamase inhibitors 1, 4
Important Caveats
- Healthcare-associated infections show different resistance patterns with higher rates of ESBL-producing organisms, multidrug-resistant gram-negatives, and enterococci (up to 47% in post-operative cases) 5
- Geographic resistance patterns must be considered, particularly ampicillin-sulbactam resistance in E. coli (now widespread) and fluoroquinolone resistance in certain regions 1
- Proper anaerobic culture technique requires direct inoculation of 1-10 mL of fluid into anaerobic blood culture bottles, as standard aerobic techniques will miss obligate anaerobes 3